Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henrik Nienhüser

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
International Journal of Molecular Sciences|January 4, 2018
Angiogenesis and Anti-Angiogenic Therapy in Gastric CancerHenrik Nienhüser, Thomas Schmidt
Zentralblatt Fur Chirurgie|February 5, 2024
[Evidence for Minimal Invasive Oesophageal Resection]Henrik Nienhüser, Thomas Schmidt
Advances in Experimental Medicine and Biology|June 29, 2021
Esophageal Tumor MicroenvironmentHenrik Nienhüser, Naita Wirsik, Thomas Schmidt
Visceral Medicine|March 17, 2022
Resection of Recurrent Pancreatic Cancer: Who Can Benefit?Henrik Nienhüser, Markus W Büchler, Martin Schneider
International Journal of Molecular Sciences|February 7, 2020
Oligometastatic Gastroesophageal Adenocarcinoma: Molecular Pathophysiology and Current Therapeutic ApproachJin-On Jung, Henrik Nienhüser, Nikolai Schleussner, et al.
Oncotarget|May 25, 2017
Inflammatory cytokines are associated with response and prognosis in patients with esophageal cancerSusanne Blank, Henrik Nienhüser, Lena Dreikhausen, et al.
The Journal of Surgical Research|June 22, 2020
Expression of Angiogenic Proteins in Tumor and Stroma Affects Survival in Patients With Gastric CancerHenrik Nienhüser, Nerma Crnovrsanin, Daniel Nerz, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|March 18, 2020
[Total minimally invasive esophagectomy]Beat Müller-Stich, Thomas Schmidt, Henrik Nienhüser, et al.
Journal of Cancer Research and Clinical Oncology|January 28, 2025
Validation of mortality risk scores after esophagectomySabine Schiefer, Nerma Crnovrsanin, Ingmar F Rompen, et al.
Journal of Cancer Research and Clinical Oncology|August 17, 2023
Pattern and time point of relapse in locally advanced esophagogastric adenocarcinoma after multimodal treatment: implications for a useful structured follow-upRamona Stelmach, Leonidas Apostolidis, Steffen Kahle, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
International Journal of Molecular Sciences|January 4, 2018
Angiogenesis and Anti-Angiogenic Therapy in Gastric CancerHenrik Nienhüser, Thomas Schmidt
Zentralblatt Fur Chirurgie|February 5, 2024
[Evidence for Minimal Invasive Oesophageal Resection]Henrik Nienhüser, Thomas Schmidt
Advances in Experimental Medicine and Biology|June 29, 2021
Esophageal Tumor MicroenvironmentHenrik Nienhüser, Naita Wirsik, Thomas Schmidt
Visceral Medicine|March 17, 2022
Resection of Recurrent Pancreatic Cancer: Who Can Benefit?Henrik Nienhüser, Markus W Büchler, Martin Schneider
International Journal of Molecular Sciences|February 7, 2020
Oligometastatic Gastroesophageal Adenocarcinoma: Molecular Pathophysiology and Current Therapeutic ApproachJin-On Jung, Henrik Nienhüser, Nikolai Schleussner, et al.
Oncotarget|May 25, 2017
Inflammatory cytokines are associated with response and prognosis in patients with esophageal cancerSusanne Blank, Henrik Nienhüser, Lena Dreikhausen, et al.
The Journal of Surgical Research|June 22, 2020
Expression of Angiogenic Proteins in Tumor and Stroma Affects Survival in Patients With Gastric CancerHenrik Nienhüser, Nerma Crnovrsanin, Daniel Nerz, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|March 18, 2020
[Total minimally invasive esophagectomy]Beat Müller-Stich, Thomas Schmidt, Henrik Nienhüser, et al.
Journal of Cancer Research and Clinical Oncology|January 28, 2025
Validation of mortality risk scores after esophagectomySabine Schiefer, Nerma Crnovrsanin, Ingmar F Rompen, et al.
Journal of Cancer Research and Clinical Oncology|August 17, 2023
Pattern and time point of relapse in locally advanced esophagogastric adenocarcinoma after multimodal treatment: implications for a useful structured follow-upRamona Stelmach, Leonidas Apostolidis, Steffen Kahle, et al.
Pageof 6